Are Syncom Formul. latest results good or bad?

Aug 08 2025 07:26 PM IST
share
Share Via
Syncom Formulations (India) reported strong financial results for the quarter ending March 2025, with a Profit After Tax of Rs 17.68 crore and record net sales of Rs 148.88 crore, both significantly higher than previous quarters. However, the reliance on non-operating income raises some concerns about sustainability.
Syncom Formulations (India) has reported its financial results for the quarter ending March 2025, showcasing notable operational trends. The company declared a Profit After Tax (PAT) of Rs 17.68 crore, which represents a significant growth compared to the average PAT of Rs 9.79 crore over the previous four quarters. This PAT is the highest recorded in the last five quarters, indicating a strong performance.

Net sales reached a record high of Rs 148.88 crore, reflecting a substantial increase from the previous four-quarter average of Rs 97.68 crore. This growth in net sales is accompanied by an operating profit (PBDIT) of Rs 17.76 crore, which has shown a consistent upward trend over the last five quarters.

Profit Before Tax (PBT) was reported at Rs 16.35 crore, marking a notable rise from the average of Rs 9.66 crore in the preceding four quarters. Additionally, the Earnings per Share (EPS) reached Rs 0.19, the highest in the last five quarters, indicating enhanced profitability for the company.

However, it is important to note that the company reported a non-operating income of Rs 6.94 crore, which may not be sustainable in the long term.

In terms of quarterly growth, the net sales for the quarter ended March 2025 showed a growth of 16.74% compared to the previous quarter, while the consolidated net profit exhibited a growth of 36.08%. The operating profit margin, excluding other income, was recorded at 11.93%, reflecting a slight change from the previous quarter.

Overall, Syncom Formulations (India) has demonstrated strong financial results, and the company saw an adjustment in its evaluation based on these outcomes.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Syncom Formul. falling/rising?
Nov 25 2025 01:16 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 19 2025 08:09 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 17 2025 08:10 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 16 2025 08:09 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 15 2025 08:10 AM IST
share
Share Via